[Federal Register Volume 71, Number 30 (Tuesday, February 14, 2006)]
[Notices]
[Pages 7782-7783]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-1324]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Board of Scientific Counselors for Clinical Sciences and 
Epidemiology National Cancer Institute.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public as indicated below in 
accordance

[[Page 7783]]

with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as 
amended for the review, discussion, and evaluation of individual 
intramural programs and projects conducted by the National Cancer 
Institute, including consideration of personal qualifications and 
performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors for Clinical 
Sciences and Epidemiology National Cancer Institute.
    Date: March 12-13, 2006.
    Closed: March 12, 2006, 6 p.m. to 10 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, National Cancer Institute, 
9000 Rockville Pike, Building 31, Conference Room 6, Bethesda, MD 
20892.
    Open: March 13, 2006, 8 a.m. to 10:30 a.m.
    Agenda: Joint Session of NCI, Board of Scientific Advisors and 
Boards of Scientific Counselors.
    Place: National Institutes of Health, National Cancer Institute, 
9000 Rockville Pike, Building 31, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Brian E. Wojcik, PhD, Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, 6116 Executive Boulevard, Room 2114, 
Bethesda, MD 20892. (301) 496-7628. [email protected].

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-government employees. 
Persons without a government I.D. will need to show a photo I.D. and 
sign-in at the security desk upon entering the building.
    Information is also available on the Institute's/Center's Home 
page: deainfo.nci.nih.gov/advisory/bsc.htm, where an agenda and any 
additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-1324 Filed 2-13-06; 8:45 am]
BILLING CODE 4140-01-M